Barney Viengkhou
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Barney
Contact Barney, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Neuropathology and Applied Neurobiology | BNS Journal | Wiley Online Library
Key Points Interleukin-6 and interferon-alpha regulate key microglia functions in opposite ways. Exposure time of cytokine stimulation affects microglia responses. Interleukin-6 stimulates microglia migration and phagocytic capability. Interferon-alpha inhibits microglia migration and phagocytic capability. INTRODUCTION Microglia play essential roles during development, homeostasis and diseases of the central nervous system (CNS), as reviewed by West et al. and Borst et al. [1, 2].
The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies
Highlights • Neurotoxic IFN-α in Aicardi-Goutières syndrome (AGS) is primarily of cerebral origin • Endothelial cells are critical cellular targets of neurotoxic IFN-α • Chronically elevated intracerebral IFN-α causes a distinct cerebral microangiopathy • Neurodegeneration arises as a secondary consequence of IFN-α-driven microangiopathy Summary Aicardi-Goutières syndrome (AGS) is an autoinflammatory disease characterized by aberrant interferon (IFN)-α production.
Interferon-α receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy
Abstract Chronic and elevated levels of the antiviral cytokine IFN-α in the brain are neurotoxic. This is best observed in patients with genetic cerebral interferonopathies such as Aicardi-Goutières syndrome. Cerebral interferonopathies typically manifest in early childhood and lead to debilitating disease and premature death. There is no cure for these diseases with existing treatments largely aimed at managing symptoms. Thus, an effective therapeutic strategy is urgently needed.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Barney
Contact Barney, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack